The CloudUPDRS Smartphone Software in Parkinson's Study.
Trial
N/A
Unknown
May 22, 2019
Modulation of Gut Microbiota by Rifaximin in PD Patients
Trial
Phase 1
Unknown
May 21, 2019
The Alouette Test in Parkinson Disease
Trial
N/A
Completed
May 20, 2019
Non-Invasive TMS Neuromodulation for Enduring Balance & Locomotion Restoration in Parkinson's Disease
Trial
N/A
Withdrawn
May 16, 2019
A Standardized Meditation Technique "Body-scan", in the Management of Anxiety in Hospitalized Parkinsonian Patients
Trial
N/A
Completed
May 16, 2019
Rock Steady Boxing vs. Sensory Attention Focused Exercise
Trial
N/A
Unknown
May 15, 2019
Repeated-Dose Oral N-acetylcysteine for the Treatment of Parkinson's Disease
Trial
Phase 2
Completed
May 15, 2019
The Efficiency of Home Based Dual Task Training in Parkinson Disease
Trial
N/A
Unknown
May 13, 2019
Psychiatric and Cognitive Manifestations of Parkinson's Disease
Trial
N/A
Completed
May 9, 2019
Mirabegron in Parkinson Disease and Impaired Cognition
Trial
Phase 4
Completed
May 7, 2019
Social Self-Management of Parkinson's Disease
Trial
N/A
Completed
May 5, 2019
Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease.
Trial
Phase 3
Terminated
May 2, 2019
Lipoprotein Metabolism and Bacterial Lipopolysaccharide in Parkinson's Disease
Trial
N/A
Completed
May 2, 2019
The Effects of Dual Task Training in Individuals With Parkinson's Disease
Trial
N/A
Completed
May 2, 2019
Impact of Exercise in Parkinson's Disease
Trial
N/A
Completed
April 25, 2019
Brain Tissue Imprint
Trial
N/A
Unknown
April 25, 2019
Effect of Deep Brain Stimulation (DBS) on Sleep Architecture in Patients With Movement Disorders
Trial
N/A
Completed
April 25, 2019
SYN120 Study to Evaluate Its Safety, Tolerability and Efficacy in Parkinson's Disease Dementia (SYNAPSE)
Trial
Phase 2
Completed
April 18, 2019
Detecting Dopaminergic Deficits in Individuals At-risk for Parkinsonism
Trial
N/A
Completed
April 17, 2019